- Home
- CHRS vs MAPS Comparison
CHRS vs MAPS Comparison
Compare CHRS & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- MAPS
- Stock Information
- Founded
- CHRS 2010
- MAPS 2008
- Country
- CHRS United States
- MAPS United States
- Employees
- CHRS N/A
- MAPS N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- MAPS Computer Software: Prepackaged Software
- Sector
- CHRS Health Care
- MAPS Technology
- Exchange
- CHRS Nasdaq
- MAPS Nasdaq
- Market Cap
- CHRS 102.0M
- MAPS 94.2M
- IPO Year
- CHRS 2014
- MAPS N/A
- Fundamental
- Price
- CHRS $1.04
- MAPS $0.97
- Analyst Decision
- CHRS Buy
- MAPS Strong Buy
- Analyst Count
- CHRS 3
- MAPS 1
- Target Price
- CHRS $4.68
- MAPS $2.61
- AVG Volume (30 Days)
- CHRS 1.3M
- MAPS 719.6K
- Earning Date
- CHRS 08-07-2025
- MAPS 08-07-2025
- Dividend Yield
- CHRS N/A
- MAPS N/A
- EPS Growth
- CHRS N/A
- MAPS N/A
- EPS
- CHRS N/A
- MAPS 0.08
- Revenue
- CHRS $272,251,000.00
- MAPS $184,737,000.00
- Revenue This Year
- CHRS N/A
- MAPS N/A
- Revenue Next Year
- CHRS $99.43
- MAPS $10.22
- P/E Ratio
- CHRS $2.44
- MAPS $11.90
- Revenue Growth
- CHRS 19.87
- MAPS N/A
- 52 Week Low
- CHRS $0.66
- MAPS $0.70
- 52 Week High
- CHRS $2.43
- MAPS $1.65
- Technical
- Relative Strength Index (RSI)
- CHRS 68.96
- MAPS 49.76
- Support Level
- CHRS $0.88
- MAPS $0.95
- Resistance Level
- CHRS $1.06
- MAPS $1.01
- Average True Range (ATR)
- CHRS 0.07
- MAPS 0.06
- MACD
- CHRS 0.02
- MAPS 0.01
- Stochastic Oscillator
- CHRS 93.38
- MAPS 50.75
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.